SANUWAVE Health Inc SNWV.OQ SNWV.O is expected to report resultson August 8 for the period ending June 30 2025
LSEG's mean analyst estimate for SANUWAVE Health Inc is for a loss of 9 cents per share.
The one available analyst rating on the shares is "buy".
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "Buy".
Wall Street's median 12-month price target for SANUWAVE Health Inc is $49.00, about 28.6% above its last closing price of $35.00
This summary was machine generated August 6 at 12:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)